ITC to Investigate Two AbbVie Competitors for Potential Use of Humira Trade Secrets

By PacConAdmin | January 28, 2022

The U.S. International Trade Commission (ITC) will investigate whether Alvotech and its partner Teva Pharmaceuticals misappropriated trade secrets in producing a biosimilar candidate for AbbVie’s autoimmune mega-blockbuster Humira (adalimumab).
Source: Drug Industry Daily

Posted in Drug Industry Daily